Piramal Pharma Limited (PPLPHARMA) — Financial Results | 30 July 2026
Piramal Pharma announced that the audio recording of its conference call on unaudited financial results for the quarter ended June 30, 2026 is now available on its website, following regulatory disclosure requirements.
About Piramal Pharma Limited (PPLPHARMA)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when PPLPHARMA files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track PPLPHARMA — Free💡 Ask AI about this filing
📊 More PPLPHARMA filings
- 🔴 Financial Results — 29 July 2026 Piramal Pharma reported consolidated revenue of **₹2,270 crores** for Q1 FY27, up 17% YoY, driven by...
- 🔴 Financial Results — 29 July 2026 Piramal Pharma reported consolidated revenue of **₹2,270 crores** for Q1FY27, up 17% YoY, driven by ...
- Announcement — 24 July 2026 Piramal Pharma disclosed a temporary suspension of operations at its Ahmedabad manufacturing facilit...
- 🔴 Financial Results — 20 July 2026 Piramal Pharma Limited announced a conference call on July 30, 2026, to discuss Q1 FY2027 results, i...
- 🔴 Annual Report — 3 July 2026 Piramal Pharma Limited submitted its Business Responsibility & Sustainability Report for FY 2025-26 ...
🔥 Also filed on 30 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when PPLPHARMA files new disclosures
Track PPLPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track PPLPHARMA — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research